Trisalus Life Sciences, Inc. 8-K Report: Key Insights & Stock Update

Here are the key insights extracted from the provided section of the financial report for Trisalus Life Sciences, Inc. (CIK: 0001826667):

1. Company Identification:

• Name: Trisalus Life Sciences, Inc.
• Location: 6272 W 91st Ave, Westminster, CO 80031
• Contact: (888) 321-5212
• SEC CIK: 0001826667
• Filing Type: 8-K
• SEC File Number: 001-39813
• EIN: 85-3009869

2. Filing Date:

• The report is dated February 18, 2025.

3. Stock Information:

• Common Stock:
• • Par Value: $0.0001
  • Ticker Symbol: TLSI
  • Exchange: NASDAQ
• Warrants:
• • Each whole warrant is exercisable for one share of common stock.
  • Exercise Price: $11.50 per share.
  • Ticker Symbol: TLSIW
  • Exchange: NASDAQ

4. Segment Information:

• The report mentions two classes of stock:
• • Common Stock
  • Warrants

5. Context and Period:

• All information is specific to the reporting period starting and ending on February 18, 2025.

Summary:

Trisalus Life Sciences, Inc. is a publicly traded company on NASDAQ, with its common stock and warrants listed under the symbols TLSI and TLSIW, respectively. The warrants provide an exercise option for purchasing shares at $11.50 each. The report is filed as an 8-K, which typically indicates a significant event or information that shareholders should be aware of. The filing date is February 18, 2025, which is crucial for understanding the timing of the reported information.